Photo

Corps éditorial
Lise Denoeud, MD, PHD is a medical epidemiologist. She has expertise in conducting clinical research and randomized trials in infectious diseases in Sub-Saharan Africa, with a focus on malaria, HIV and tuberculosis. Her interests include work on vulnerable populations such as pregnant women and children, co-infections and co-morbidities, and integrated strategies. She (re)joined EPICENTRE/MSF Research Department in February 2025 as a senior medical epidemiologist, with main focus on malaria clinical trials. She is based in MSF switzerland.
A multi-center, open-label trial to compare the efficacy and pharmacokinetics of Artemether-Lumefantrine in children with severe acute malnutrition versus children without severe acute malnutrition: study protocol for the MAL-NUT study.
Journal Reference:
BMC infectious diseases 2015 Jun 12; 15 228. doi: 10.1186/s12879-015-0963-3. Epub 2015 06 12
Early biting and insecticide resistance in the malaria vector Anopheles might compromise the effectiveness of vector control intervention in Southwestern Uganda.
Journal Reference:
Malaria journal 2015 Apr 09; 14 148. doi: 10.1186/s12936-015-0653-z. Epub 2015 04 09
Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and Niger.
Journal Reference:
BMC medicine 2016 10 24; 14(1); 167. doi: 10.1186/s12916-016-0716-1. Epub 2016 10 24
Severe acute malnutrition results in lower lumefantrine exposure in children treated with artemether-lumefantrine for uncomplicated malaria.
Journal Reference:
Clinical pharmacology and therapeutics 2019 Jun 01; . doi: 10.1002/cpt.1531. Epub 2019 06 01